Hogan, Michael C., L. Bruce Gladden, Bruno Grassi, Creed M. Stary, and Michele Samaja. Bioenergetics of contracting skeletal muscle after partial reduction of blood flow. J. Appl. Physiol. 84(6): 1882-1888, 1998.-The purpose of this study was to examine the bioenergetics and regulation of O 2 uptake (V O 2 ) and force production in contracting muscle when blood flow was moderately reduced during a steadystate contractile period. Canine gastrocnemius muscle (n ϭ 5) was isolated, and 3-min stimulation periods of isometric, tetanic contractions were elicited sequentially at rates of 0.25, 0.33, and 0.5 contractions/s (Hz) immediately followed by a reduction of blood flow [ischemic (I) condition] to 46 Ϯ 3% of the value obtained at 0.5 Hz with normal blood flow. The V O 2 of the contracting muscle was significantly (P Ͻ 0.05) reduced during the I condition [6.5 Ϯ 0.8 (SE) ml · 100 g Ϫ1 · min Ϫ1 ] compared with the same stimulation frequency with normal flow (11.2 Ϯ 1.5 ml · 100 g Ϫ1 · min Ϫ1 ), as was the tension-time index (79 Ϯ 12 vs. 123 Ϯ 22 N·g Ϫ1 · min Ϫ1 , respectively). The ratio of V O 2 to tension-time index remained constant throughout all contraction periods. Muscle phosphocreatine concentration, ATP concentration, and lactate efflux were not significantly different during the I condition compared with the 0.5-Hz condition with normal blood flow. However, at comparable rates of V O 2 and tension-time index, muscle phosphocreatine concentration and ATP concentration were significantly less during the I condition compared with normal-flow conditions. These results demonstrate that, in this highly oxidative muscle, the normal balance of O 2 supply to force output was maintained during moderate ischemia by downregulation of force production. In addition, 1) the minimal disruption in intracellular homeostasis after the initiation of ischemia was likely a result of steady-state metabolic conditions having already been activated, and 2) the difference in intracellular conditions at comparable rates of V O 2 and tension-time index between the normal flow and I condition may have been due to altered intracellular O 2 tension. oxygen uptake; exercise; adenosine 5Ј-triphosphate; lactate; lactic acid; mitochondrial respiration; phosphocreatine; glycolysis IN MOST CONDITIONS of steady-state muscle contractile activity, ATP production related to the O 2 uptake (V O 2 ) of the contracting muscle is tightly coupled to the rate of ATP demand so that steady-state energy expenditure is maintained with minimal change in intracellular ATP concentration ([ATP]; e.g., see Ref. 12). When the supply of O 2 (and oxidative substrate) to the mitochondria is sufficient, increases in myofibril ATPase activity with higher energy demands result in changes in the concentration of several signals [phosphocreatine (PCr), ADP, P i , etc.] that are thought to regulate mitochondrial respiration (4, 5, 18, 20, 22) in a manner that causes oxidative phosphorylation to increase proportionally with ATPase activity. However, when the supply of O 2 to the mitochondria is insufficient, the tight coupling between the ATP demand of the myofibril ATPases and the ATP supply by mitochondrial respiration may be disrupted, and an increased reliance on ATP regeneration derived from substrate-level phosphorylation (PCr hydrolysis and anaerobic glycolysis) may ensue. The result of prolonged mitochondrial O 2 limitation can be a downregulation of ATPase activity, thereby reducing force development, so that ATP demand does not exceed the reduced ATP production.
IN MOST CONDITIONS of steady-state muscle contractile activity, ATP production related to the O 2 uptake (V O 2 ) of the contracting muscle is tightly coupled to the rate of ATP demand so that steady-state energy expenditure is maintained with minimal change in intracellular ATP concentration ([ATP]; e.g., see Ref. 12) . When the supply of O 2 (and oxidative substrate) to the mitochondria is sufficient, increases in myofibril ATPase activity with higher energy demands result in changes in the concentration of several signals [phosphocreatine (PCr), ADP, P i , etc.] that are thought to regulate mitochondrial respiration (4, 5, 18, 20, 22) in a manner that causes oxidative phosphorylation to increase proportionally with ATPase activity. However, when the supply of O 2 to the mitochondria is insufficient, the tight coupling between the ATP demand of the myofibril ATPases and the ATP supply by mitochondrial respiration may be disrupted, and an increased reliance on ATP regeneration derived from substrate-level phosphorylation (PCr hydrolysis and anaerobic glycolysis) may ensue. The result of prolonged mitochondrial O 2 limitation can be a downregulation of ATPase activity, thereby reducing force development, so that ATP demand does not exceed the reduced ATP production.
When mitochondrial O 2 limitation is caused by reduced O 2 availability due to inadequate blood flow (ischemia), there is evidence that the manner in which the blood flow reduction is imposed may influence muscle metabolism and the degree of impairment of contractile function (12, 16, 17, 31) . Timmons et al. (28) (29) (30) recently demonstrated that substrate availability through the pyruvate dehydrogenase complex (PDC) for carbohydrate oxidation in the tricarboxylic cycle can affect subsequent muscle performance during moderate ischemia. These investigators (30) demonstrated that having the PDC enzyme fully activated at the onset of an ischemic contractile period resulted in significantly less PCr hydrolysis and lactate accumulation and subsequently less fatigue compared with the same ischemic blood flow reduction with PDC starting from the normal resting deactivated state.
Although there has been extensive investigation of the coupling of cell respiration to force production under conditions of adequate O 2 availability to the mitochondria, there has been substantially less research done concerning the manner in which muscle reestablishes steady-state conditions when O 2 availability becomes limiting. The purpose of the present study was to investigate the control of coupling of muscle force output to the rate of mitochondrial respiration when the O 2 supply to the mitochondria was insufficient to meet the energy demand. In addition, we tested the hypothesis that having the muscle in an aerobic steady state of contractile activity with normal blood flow, in which the PDC and other regulatory enzymes were fully activated, would minimize the metabolic disruption when partial ischemia was induced.
METHODS
Five adult mongrel dogs of either sex with a weight range of 12-19 kg were anesthetized with pentobarbital sodium (30 mg/kg). Maintenance doses were given as required. The dogs were intubated with cuffed endotracheal tubes, and ventilation was maintained with a Harvard 613 ventilator at a rate that achieved normal values of arterial PO 2 and PCO 2 . Esophageal temperature was maintained near 37°C by the use of heating pads. The animals were given heparin at a dosage of 1,500 U/kg after the surgery.
Surgical preparation. The left gastrocnemius-flexor digitorum superficialis muscle complex (for convenience referred to as gastrocnemius) was isolated as described previously (15) . Briefly, the muscle was isolated from nearby muscle groups, and all vessels draining into the popliteal vein except for those from the gastrocnemius were ligated to isolate the venous outflow from the gastrocnemius. The arterial circulation to the gastrocnemius was isolated by ligating all vessels from the femoral and popliteal artery that did not enter the gastrocnemius. The left popliteal vein was cannulated, and the venous outflow from the isolated muscle was returned to the animal via a jugular catheter.
The right femoral artery was catheterized for arterial blood sampling. This catheter was connected to the left femoral artery so that the isolated muscle was perfused by blood from this contralateral artery. Perfusion was accomplished either directly from the contralateral (systemic pressure, selfperfused) or via a Sigmamotor pump to control flow. All experimental conditions were conducted with blood flow perfusion controlled by the pump. A pressure transducer in this line at the head of the muscle constantly monitored perfusion pressure. A carotid artery was also catheterized to monitor systemic blood pressure. The left sciatic nerve, which innervates the gastrocnemius, was doubly ligated and cut between ties. To prevent cooling and drying, all exposed tissues were covered with saline-soaked gauze and with a sheet of Saran. After the muscle was surgically isolated, the Achilles tendon was attached to an isometric myograph to measure force development.
The hindlimb was fixed at the knee and ankle and attached to the myograph with struts to minimize movement. Weights were used at the end of each experiment to calibrate the force myograph. The isometric force developed by each muscle was normalized to the weight of that muscle. Before each contraction period, the resting muscle was passively stretched until the force produced by a single tetanic contraction was maximal.
Experimental protocol. Isometric muscle contractions (tetanic) were elicited by stimulation of the sciatic nerve with square-wave impulses (6-8 V) of 0.2-ms duration at a rate of 50 impulses/s, with this train of impulses lasting 0.2 s (so 10 impulses during each contraction). Each muscle (n ϭ 5) was stimulated to contract in a consecutive manner for 3-min at each of three stimulation frequencies: one contraction every 4 (0.25 Hz), 3 (0.33 Hz), and 2 (0.5 Hz) s. Muscle blood flow for these three stimulation patterns was set at a rate that kept muscle perfusion pressure at ϳ130 mmHg. After 3 min of the 0.5-Hz stimulation (highest contractile intensity; ϳ60-70% of the peak V O 2 ), the blood flow was immediately reduced by ϳ50% so that O 2 delivery was reduced 50% [ischemia (I)]. Muscle force development was then allowed to stabilize at a new steady state, which typically took ϳ3-4 min.
Measurements. Arterial blood samples from the arterial line entering the muscle and venous samples from the left popliteal vein as close to the gastrocnemius as possible were drawn anaerobically at the end of each rest period, at the end of each 3-min contraction period, and at the end of the moderate-ischemia period. These samples were kept on ice for the brief time before measurement. Venous blood flow measurements were made at the same time the blood samples were drawn by timed blood collections into a graduated cylinder. Barbee et al. (1) , using muscle contractions similar to those used in this investigation, determined that a steadystate flow and V O 2 had been achieved by the end of 2 min.
Muscle biopsies were obtained immediately after the blood measurements were taken. These biopsies were obtained by using the Bergstrom needle-biopsy technique (3) and frozen in liquid N 2 within 2-4 s. In all, five biopsies were obtained from each muscle from separate randomly selected sites (1 at rest, 1 at the end of the 3 different stimulation periods, and 1 at the end of the I condition). The dog gastrocnemius is composed of only high-oxidative fibers (type I and IIa; Ref. 19) , with ϳ50% being slow oxidative (type I), so there should be little variability in fiber type distribution throughout the more superficial areas of the muscle where biopsy sampling occurred. The muscle was removed and weighed at the end of each experiment.
Muscle force development was measured from the chart recordings and reported as newtons per 100 grams of muscle mass. Muscle fatigue was calculated as the decline in muscle force development with time and was reported as the tension development at that time as a percentage of the initial tension development for that condition. The tension-time index was used as an indication of ATP demand and was calculated as isometric force produced for a fixed amount of time (newtons of force developed per gram of muscle per minute).
Blood lactate concentrations were determined (after red cell lysing) from the arterial and venous samples by using a Yellow Springs Instruments 23L blood lactate analyzer. Blood PO 2 , PCO 2 , and pH were measured within 5-8 min with a blood-gas analyzer [ among muscles and did not change throughout the experimental period. Perfusion pressure to the contracting muscle was kept constant at 130 Ϯ 8 mmHg for the three contraction periods (0.25, 0.33, and 0.5 Hz) with normal blood flow. Muscle blood flow increased in a linear fashion with increasing stimulation frequency (significant increase with each change) and was reduced significantly (to 46% of the value obtained at 0.5 Hz with normal flow; P Ͻ 0.05) during the I condition, as shown in Fig. 1A . Because [Hb] and arterial PO 2 did not change, O 2 delivery to the muscle was proportional to muscle blood flow and thereby mirrored the blood flow changes seen in Fig. 1 (O 2 delivery ϭ 11.9, 14.2,  18 .0, and 8.3 ml O 2 · 100 g Ϫ1 · min Ϫ1 for the 0.25-Hz, 0.33-Hz, 0.5-Hz, and I conditions, respectively).
As illustrated in Fig. 1B , the tension-time index (index of muscle force production for a fixed time period) increased linearly for the three stimulation patterns with normal blood flow (significant increase with each change) but was significantly reduced from the 0.5-Hz stimulation period during the I condition to a level not significantly different from that during the 0.25-Hz stimulation period. The peak developed force did not fall as the stimulation frequency was increased from 0.25 to 0.33 to 0.5 Hz; peak developed force only fell (to 65% of normal) when the I condition was imposed. V O 2 changes are shown in Fig. 1C and were similar to the changes seen in the tension-time index ( Lactate output by the muscle was not significantly different among the three normal blood flow conditions and the I condition (6 Ϯ 6, 7 Ϯ 10, 20 Ϯ 13, 26 Ϯ 13 µmol · 100 g Ϫ1 · min Ϫ1 , respectively). 
DISCUSSION
This study demonstrated that when a moderate reduction of blood flow (to 46% of normal) was imposed on normally perfused, aerobically contracting skeletal muscle, force development was downregulated until the normal relationship of mitochondrial respiration and force production was restored. Muscle [PCr], [ATP], and lactate efflux were not altered significantly by the I condition compared with the same stimulation frequency with normal blood flow. The insignificant changes in these variables during these partial ischemic conditions, even when force production and respiration were reduced by 50%, was likely due to the blood flow reduction occurring after steady-state conditions of respiration and force in the contracting muscle had been established.
Relationship between V O 2 and force production. Although the regulators of mitochondrial respiration in skeletal muscle have been well studied (4, 5, 18, 20, 22) when O 2 supply to the mitochondria is adequate, the manner in which mitochondrial respiration and muscle force production are coupled when O 2 availability is compromised has been less well documented. If nonoxidative sources for ATP rephosphorylation are recruited when O 2 availability becomes rate limiting, then force production can be maintained to some degree by anaerobic glycolysis and PCr hydrolysis (substrate-level phosphorylation). However, continued high rates of substrate-level phosphorylation can lead to alterations in the intracellular environment that can ultimately result in cellular damage if the ATPase activity is not adjusted. It has been demonstrated that skeletal muscle (12, 16, 17, 31) , especially muscle rich with highoxidative fibers, has some capacity to minimize intracellular disruption of homeostasis when O 2 availability becomes limiting by simply downregulating force production (ATPase activity) to match flux through oxidative phosphorylation, with minimal activation of substrate-level phosphorylation. Although respiration and force production can be dramatically reduced under these conditions, there may only be minor changes in the intracellular concentrations of ATP, PCr, and lactate. This stategy maintains the ''tight coupling'' (10) of force production to mitochondrial respiration so that the O 2 cost of the contractions remains constant.
The manner by which muscle can minimize intracellular metabolic disruption, by downregulating ATPase activity to match the rate of oxidative phosphorylation, during conditions of partial ischemia is not well understood. Timmons et al. (28, 30) have recently demonstrated that activating the PDC before the initiation of an ischemic contractile period resulted in less depletion of muscle PCr and ATP, lower lactate accumulation, and enhanced subsequent force production compared with the control ischemic situation with no PDC activation. This indicates that when partial ischemia was imposed on contracting muscle at the onset of contractions, substrate availability for oxidative phosphorylation was inadequate and the reduced O 2 availability was not the only factor determining subsequent muscle performance. The present study demonstrated that when O 2 availability was reduced after normal steadystate conditions had been reached (fully aerobic contractions), the tight coupling of force production to respiration was maintained (see Fig. 3 ), as has been shown before in this highly oxidative muscle for moderate ischemia conditions (2, 6, 8, 9, 26) . Muscle [ATP], [PCr] , and lactate efflux during the I condition were not significantly different from the values seen at the same stimulation intensity with normal blood flow. Timmons et al. (29) found muscle [PCr] and [ATP] to be significantly more depleted (and found greater lactate accumulation) in contracting muscle when partial ischemia was imposed from the onset of contractions compared with a control condition at the same stimulation frequency but with normal blood flow. It is likely that in the present study, the lack of any significant differences in muscle [PCr] , [ATP] , and lactate efflux beween the I condition and the same stimulation with normal blood flow was due to the fact that the muscle was in a steady state of contractile activity, with all regulatory enyzmes fully activated, when the partial ischemia was induced. Our results, therefore, support the notion that prior activation of key regulatory enzymes before initiation of partial ischemia (30) may enhance cellular homeostasis and muscle function.
The question then arises as to the mechanism(s) by which, in the present study, the muscle reduced force development to the level at which the new steady-state force production was exactly matched to the rate of respiration that could be achieved from the limited amount of O 2 available. There was no fall in peak developed force through the three normal blood flow contraction periods (0.25, 0.33, and 0.5 Hz), and the tension-time index increased in a linear manner with stimulation frequency (see Fig. 1B ). However, after the reduction of muscle blood flow during the I condition, there was an immediate (within 2-3 contractions) fall in peak developed force until a new steady state was established within 3-4 min at a peak force development 65% of the value found before blood flow reduction. In this whole-muscle model, we cannot distinguish whether the reduction in force development at the onset of ischemia was a result of some fibers (possibly fibers with more ''fast-twitch'' characteristics) shutting down due to O 2 deprivation (potentially from heterogeneous blood flow distribution) or whether all fibers simply reduced force development proportionally. The factors that cause the reduction in force development in contracting muscle over time, when stimulation patterns remain constant, are complex (7, 32, 34) . During contractions with ischemic blood flow reduction, there can be an accumulation of intracellular metabolites that can affect contractility and long-term muscle performance (2, 25) . However, the immediate fall in force development in this muscle is primarily related to O 2 availability (14), independent of blood flow. As discussed, there was little change in muscle P i concentration (inversely related to [PCr] ) and lactate efflux during the I condition compared with the same stimulation frequency with normal blood flow. Increased levels of H ϩ and P i have been implicated (21, 27, 33, 36) in the rapid development of high-intensity contractile fatigue by interfering with Ca 2ϩ release, Ca 2ϩ binding, or actomyosin binding (see Refs. 7, 32, and 34). It is likely that alterations in processes directly related to regulation of intracellular Ca 2ϩ release were important in the reduction of force development during ischemia in the present study. (Fig. 4) , the estimated [ATP]/ [ADP][P i ] ratio (ADP estimated from previous studies; 11, 13) was reduced to 25% in the I condition compared with the value of this ratio in the 0.25-Hz condition with normal blood flow. Thus, at the same rate of respiration and force output, the I condition had a significantly altered intracellular environment.
As has been demonstrated previously (2, 6, 9, 13, 26) , as blood flow was reduced in the present study the muscle was able to extract a higher percentage of the O 2 delivered by convective blood flow. A greater diffusion of O 2 to the mitochondria (for a higher extraction) was likely accomplished by reductions in intracellular PO 2 . We have suggested previously (11, 12) Conclusion. This study demonstrated that in contracting, highly oxidative muscle, a moderate blood flow reduction (with equivalent reductions in O 2 availability) reduced the tension-time index to the point at which the normal relationship of the tension-time index and mitochondrial respiration was restored. With the blood flow reduction imposed after normal steadystate conditions of blood flow, respiration, and force output had already been achieved in a contractile period, there was little disruption of the intracellular environment as force was downregulated. This was likely a result of substrate availabilty and enzymatic processes being already adequately activated. In addition, the significant differences in muscle [ATP] and [PCr] between the I condition and the contraction period (0.25 Hz with normal blood flow) that had a similar rate of respiration and tension-time index may in part have been due to an effect of reduced intracellular PO 2 on the regulators of oxidative phosphorylation.
